Comparing Individual Angiotensin-Converting Enzyme Inhibitors with Angiotensin Receptor Blockers on the Risk of Pneumonia: A Nationwide Cohort Study

被引：0
|
作者：
Ruan, Sheng-Yuan [1 ,2 ]
Chang, Chia-Hsuin [1 ,2 ]
Lee, Yen-Chieh [3 ]
Wu, Li-Chiu [1 ]
Lai, Mei-Shu [1 ]
机构：
[1] Natl Taiwan Univ, Inst Prevent Med, Coll Publ Hlth, Taipei 10764, Taiwan
[2] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan
[3] Cathay Gen Hosp, Dept Family Med, Taipei, Taiwan
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2014年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
859
引用
收藏
页码：461 / 462
页数：2
相关论文
共 50 条
  • [1] Comparing individual angiotensin-converting enzyme inhibitors with losartan in the risk of hospitalization for pneumonia and related mortality: a nationwide cohort study
    Chang, Chia-Hsuin
    Lin, Jou-Wei
    Ruan, Sheng-Yuan
    Lee, Yen-Chieh
    Wu, Li-Chiu
    Lin, Min-Shung
    Lai, Mei-Shu
    JOURNAL OF HYPERTENSION, 2015, 33 (03) : 634 - 643
  • [2] Pneumonia Risk and Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
    Liu, Chia-Lin
    Shau, Wen-Yi
    Chang, Chia-Hsuin
    Wu, Chi-Shin
    Lai, Mei-Shu
    JOURNAL OF EPIDEMIOLOGY, 2013, 23 (05) : 344 - 350
  • [3] Renal Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients with Liver Cirrhosis: A Nationwide Cohort Study
    Hsu, Wei-Fan
    Yu, Shi-Hang
    Lin, Jaw-Town
    Wu, Jaw-Ching
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    Wu, Chun-Ying
    Peng, Cheng-Yuan
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2019, 2019
  • [4] Use of β-Blockers, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Risk of Breast Cancer Recurrence: A Danish Nationwide Prospective Cohort Study
    Sorensen, Gitte Vrelits
    Ganz, Patricia A.
    Cole, Steven W.
    Pedersen, Lars A.
    Sorensen, Henrik Toft
    Cronin-Fenton, Deirdre P.
    Garne, Jens Peter
    Christiansen, Peer M.
    Lash, Timothy L.
    Ahern, Thomas P.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (18) : 2265 - +
  • [5] Angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, and risk of appendicitis
    Mukamal, Kenneth J.
    Ghimire, Sanjay
    Pandey, Rudra
    Fiarman, Gale S.
    Gautam, Shiva
    ANNALS OF EPIDEMIOLOGY, 2012, 22 (10) : 747 - 750
  • [6] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in atherosclerosis
    Lonn E.
    Current Atherosclerosis Reports, 2002, 4 (5) : 363 - 372
  • [7] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high vascular risk
    Potier, Louis
    Roussel, Ronan
    Elbez, Yedid
    Marre, Michel
    Zeymer, Uwe
    Reid, Christopher M.
    Ohman, Magnus
    Eagle, Kim A.
    Bhatt, Deepak L.
    Steg, Philippe Gabriel
    HEART, 2017, 103 (17) : 1339 - 1346
  • [8] Fracture Risk and Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers
    Holloway-Kew, Kara L.
    Betson, Amelia G.
    Anderson, Kara B.
    Sepetavc, Filip
    Gaston, James
    Kotowicz, Mark A.
    Liao, Wan-Hui
    Henneberg, Maciej
    Pasco, Julie A.
    CALCIFIED TISSUE INTERNATIONAL, 2022, 111 (04) : 396 - 408
  • [9] Fracture Risk and Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers
    Kara L. Holloway-Kew
    Amelia G. Betson
    Kara B. Anderson
    Filip Sepetavc
    James Gaston
    Mark A. Kotowicz
    Wan-Hui Liao
    Maciej Henneberg
    Julie A. Pasco
    Calcified Tissue International, 2022, 111 : 396 - 408
  • [10] Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Myocardial Infarction
    Kostis, John B.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2019, 24 (04) : 397 - 397
12345